Abstract
Tumor antigens are of interest as diagnostic and prognostic
markers and potential therapeutic targets. The tumor antigen
preferentially expressed antigen of melanoma (PRAME) is
frequently overexpressed in a wide variety of cancers and is a
prognostic marker for clinical outcome. It has been shown
recently that PRAME functions as a repressor of retinoic acid
signaling. Here,
... read more